Long COVID-19 Treatment Trial
The study has been approved by the Human Research Ethics Commitee EC00436, and is registered at the ANZCTR clinical trial registry: ACTRN12622001204730p
Project explanation and objectives
A large number of people experience long-COVID symptoms persisting for weeks and months after overcoming the acute illness. Symptoms include chronic fatigue, breathlessness, joint pain, cough, neurological diseases, loss of sense of smell and/or taste.
This cohort study aims to explore the underlying causes of long COVID symptoms, and assess treatment effectiveness of a staged treatment approach of 2x 6 weeks.
This study is exploratory, and will provide important insights for protocol development for a larger cohort study.
Who can participate in this study?
You had Covid-19 and tested positive on a PCR or RAT test more than 3 months ago, and have persistent symptoms for longer than 3 months, and have a doctor’s referral.
The study involves:
- A series of online questionnaires focusing on your symptoms and medical history
- 3 appointments with the trial doctor over a period of 3 months
- Blood tests at baseline and 12 weeks include standard pathology tests and the NIIM Rare Cell & Pathogen Test
- After review of the blood test results, the trial doctor will refer you to Stage 1 intervention (0-6 weeks):
The first 6 weeks’ treatment period will be the same for all participants, and includes food-based nutrients and supplements.
- At 6 week assessment by online questionnaire and the trial doctor. The trial doctor will allocate you to one in three intervention groups.
- Stage 2 (7-12th week): The second 6 week treatment program will be conducted in 3 groups:
Group 1: Intravenous Vitamin C therapy (IVC) – NIIM Clinic in Melbourne, VIC
Group 2: Kyolic & Curcumin & Omega-3 & NAC (N-acetyl-cysteine)
Group 3: Continuation of the food-based nutritional protocol
- Final assessment by online questionnaire and trial doctor at 12 weeks
For Expressions of Interest, go to the Long-COVID-Trial online Questionnaire: